Search

Author/Creator Assudani, Deepak

1. Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects. (1st December 2016)

Authors:
Wynne, Christopher; Altendorfer, Mario; Sonderegger, Ivo; Gheyle, Lien; Ellis-Pegler, Rod; Buschke, Susanne; Lang, Benjamin; Assudani, Deepak; Athalye, Sandeep; Czeloth, Niklas
Journal:
Expert opinion on investigational drugs
Issue:
Volume 25:Number 12(2016:Dec.)
Page Start:
1361
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial. Issue 10222 (8th February 2020)

Authors:
Ritchlin, Christopher T; Kavanaugh, Arthur; Merola, Joseph F; Schett, Georg; Scher, Jose U; Warren, Richard B; Gottlieb, Alice B; Assudani, Deepak; Bedford-Rice, Kathy; Coarse, Jason; Ink, Barbara; McInnes, Iain B
Journal:
Lancet
Issue:
Volume 395:Issue 10222(2019)
Page Start:
427
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0108 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAÏVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY. (June 2019)

Authors:
Ritchlin, Christopher T.; Kavanaugh, Arthur; Merola, Joseph F.; Schett, Georg; Scher, Jose U.; Warren, Richard B.; Assudani, Deepak; Kumke, Thomas; Ink, Barbara; Mcinnes, Iain
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1087Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants. (December 2014)

Authors:
Scheifele, David W.; Ferguson, Murdo; Predy, Gerald; Dawar, Meena; Assudani, Deepak; Kuriyakose, Sherine; Van Der Meeren, Olivier; Han, Htay Htay
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study. Issue 6 (7th March 2018)

Authors:
Cohen, Stanley B; Alonso-Ruiz, Alberto; Klimiuk, Piotr A; Lee, Eric C; Peter, Nuala; Sonderegger, Ivo; Assudani, Deepak
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77:Issue 6(2018)
Page Start:
914
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OA36 Bimekizumab in patients with psoriatic arthritis: achievement and maintenance of Psoriatic Arthritis Response Criteria responses through 3 years in a phase 2b open-label extension study. (23rd April 2022)

Authors:
Tillett, William; McInnes, Iain B; McGonagle, Dennis; Jadon, Deepak R; Ink, Barbara; Assudani, Deepak; Coarse, Jason; Eells, Jason; Coates, Laura C
Journal:
Rheumatology
Issue:
Volume 61(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study. Issue 12 (18th November 2022)

Authors:
Coates, Laura C.; McInnes, Iain B.; Merola, Joseph F.; Warren, Richard B.; Kavanaugh, Arthur; Gottlieb, Alice B.; Gossec, Laure; Assudani, Deepak; Bajracharya, Rajan; Coarse, Jason; Ink, Barbara; Ritchlin, Christopher T.
Journal:
Arthritis & rheumatology
Issue:
Volume 74:Issue 12(2022)
Page Start:
1959
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants. Issue 16 (15th April 2015)

Authors:
Scheifele, David W.; Ferguson, Murdo; Predy, Gerald; Dawar, Meena; Assudani, Deepak; Kuriyakose, Sherine; Van Der Meeren, Olivier; Han, Htay-Htay
Journal:
Vaccine
Issue:
Volume 33:Issue 16(2015)
Page Start:
1897
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study. Issue 3 (3rd March 2016)

Authors:
Anh, Dang Duc; Van Der Meeren, Olivier; Karkada, Naveen; Assudani, Deepak; Yu, Ta-Wen; Han, Htay Htay
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 12:Issue 3(2016)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗